Module 3 Pre-Test Buprenorphine Medical Management: Monitoring the Patient

PRE-TEST SURVEY

Please complete the following pre-test to help us assess your knowledge of the course material prior to completing this training session.

IMPORTANT!!
Once you complete the pre-test and FINISHED, you will be able to view your test results. After viewing your results, click DONE.

If you have difficulties completing this survey, please contact Amy Wales at amy.wales@miccsi.org.

Demographics

Question Title

* 1. Personal Information

First Name

Last Name

Credential

Question Title

* 2. Please choose your organization from the choices below:

Affinia Health Network-Lakeshore (Lakeshore Health Network)

Answer Health (WMPN/POWM)

Borgess Health/Ascension

Bronson Healthcare

Blue Cross Blue Shield of Michigan or Blue Care Network

CIPA

Covenant Healthcare

Genesys

Great Lakes Bay Health

Great Lakes PHO

Henry Ford Health System

Holland PHO

Huron Valley Physicians Association (HVPA)

IHA

Lakeland Care

McLaren Health

Mercy Health Physicians Partners-Grand Rapids

Munson Healthcare

Metro Health

Northern Physician Organization (NPO)

Priority Health

Spectrum Health

Thunder Bay Health Centers

University of Michigan

Upper Peninsula Health System

Wexford PHO

Other (please specify)

Question Title

* 3. Please list the name of your practice. If not applicable, type "N/A".

Question Title

* 4. Please choose your role in your practice:

Physician

Advanced practice provider (physician assistant, nurse practitioner, etc.)

Nurse care manager/care coordinator

Social worker care manager/behavioral health specialist

Pharmacist

Leadership

Other clinical (CMA, RMA, etc.)

Other non-clinical (support staff, etc.)

Other (please specify)

Pre-Training Confidence Assessment

Please use the following scale to answer questions 5 and 6.

1: Not confident at all
2: Slightly confident
3: Somewhat confident
4: Fairly confident
5: Completely confident

Question Title

* 5. On a scale of 1-5 please rate your confidence in managing substance use disorder.

Question Title

* 6. On a scale of 1-5 please rate your confidence in monitoring patients with substance use disorder.

Pre-Training Knowledge Assessment

Question Title

* 7. Which of the following statements is/are true?

Drug testing can be used as the sole measure of a patient’s substance use.

A positive drug test provides sufficient evidence for a diagnosis of substance use disorder.

Drug testing can be used as an important element in treatment planning and adjustment.

All of the above

Question Title

* 8. Which of the following is/are true regarding monitoring buprenorphine therapy?

The norbuprenorphine to buprenorphine (N:B) concentration can assist with identifying sample tampering.

Urine testing is a common mechanism for monitoring adherence to buprenorphine therapy.

Routine buprenorphine immunoassays cannot distinguish between patients who are taking buprenorphine as prescribed and those who have “spiked” their urine.

All of the above

Question Title

* 9. Which of the following is NOT typically used to assess for specimen validity?

Ketones

Creatinine concentration

pH level

Specific gravity

Question Title

* 10. Hair testing ____________.

Is routinely used in the addiction treatment setting.

Is not appropriate for most addition treatment settings.

Can provide a window of detection of appropriately 10 years.

Both B and C.